Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
The intact gadolinium chelate is paramagnetic and shortens T1 relaxation times to increase MRI signal intensity in tissues where it distributes. It is a diagnostic contrast complex, and its use is restricted or contraindicated in patients at risk of nephrogenic systemic fibrosis (NSF).
Indications / reported uses
Historical contrast-enhancement use for MRI of the central nervous system and selected body regions; gadodiamide is contraindicated or heavily restricted in severe renal impairment in many jurisdictions due to NSF risk. Verify current local availability and product status.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Gadodiamide PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Gadodiamide Permitted Daily Exposure (PDE) report (the Gadodiamide PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Gadodiamide Occupational Exposure Limit (OEL) report (the Gadodiamide OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.